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Introduction. The Department for Internal and Integrative Medicine in Essen utilizes mind/body medical elements in order to
empower patients with chronic diseases to better cope with their symptoms and to adopt a healthy lifestyle. This study explored
the influence and predictors of a 2-week integrative treatment program on patients’ quality of life. Methods. This observational
study was conducted with inpatients as part of the quality assurance program. Patients’ quality of life, psychological symptoms,
and health locus of control were measured on admission and discharge and again 3, 6, and 12 months after discharge. Regression
analyses were conducted to determine the factors predicting improved quality of life. Results. Data from 2486 inpatients treated
in 2001–2004 were included (80% female, mean age 53.9 ± 14.3 years). Response rates decreased to 50% at 12 months. Small-
to-moderate eﬀects were found on patients’ quality of life, anxiety, and depression. Patients’ internal locus of control significantly
increased. Improved quality of life was mainly predicted by lower baseline scores. Conclusion. Results of this study suggest that a
2-week inpatient treatment might sustainably reduce patients’ symptoms and increase their quality of life; however, conclusions
are only preliminary. More research is needed to enable the eﬀectiveness to be judged conclusively.
1. Introduction
Integrative treatment approaches are becoming increasingly
important. This is especially the case in treating chronic
diseases; long-term conditions that develop slowly over time
often progress in severity and rarely can be cured [1]. Treat-
ing such diseases, including musculoskeletal, cardiovascular,
digestive, and metabolic disorders, uses up nearly 80% of
nations’ health budgets and imposes immense individual
burdens [2–4]. Chronic diseases impair physical and mental
health and reduce one’s ability to carry out activities of daily
living [5]. For example, studies have shown that physical
illness is an important risk factor for anxiety and depression
[6, 7] and that depression is a risk factor for physical illness
[8].
Although much progress has been made to date in drug
development and medical technology, patients and their
psychosocial needs are less often involved in the therapeutic
process. Despite the eﬀect that psychological health and
lifestyle factors are known to have on health and disease
in patients with chronic health conditions [9], few change
their lifestyles [10]. Empowering patients to adopt healthy
lifestyles may enhance the eﬀects of any treatments received
and reduce future health risks.
The Department for Internal and Integrative Medicine
at Kliniken Essen-Mitte, the University of Duisburg-Essen’s
academic teaching hospital, was established in 1999. The
Clinic combines conventional medicine, complementary
medicine, and Mind/Body therapies to treat patients with
chronic diseases [11, 12]. The Mind/Body therapies were
added specifically to promote patients’ active participation
in their care. Mind/Body therapies are defined as “practices
that focus on the interactions between the brain, mind,
body, and behaviour, with the intention of using the
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mind to aﬀect physical functioning and promote health”
[13]. Such therapies include lifestyle education: seeking
to enhance patients’ capacity for self-care through such
elements as exercise, good nutrition, relaxation, and self-
help [12, 14, 15]. Although Mind/Body programs are not
overtly psychotherapeutic, aspects of cognitive behavioural
therapy are used to enhance patients’ ability to cope with
their condition, and its impact on daily life, and to live a
healthy lifestyle. Research shows such programs’ eﬀectiveness
for conditions including coronary heart disease [16–18],
inflammatory bowel disease [19, 20], and cancer [21].
Patients’ control beliefs are also considered key in ensuring
long-term treatment eﬀectiveness [22]. Patients who have an
internal locus of control (believe that they are able improve
their own health) should use active coping strategies more
often than other patients.
This observational study was conducted to explore the
influence of a 2-week integrative treatment program on
patients’ quality of life, psychological symptoms, and locus
of control and to determine the factors predicting improved
quality of life.
2. Methods
2.1. Design and Patients. This observational study was con-
ducted at the Department for Internal and Integrative
Medicine in Essen [11], Germany, as part of its ongoing
quality assurance program. The Clinic was established as a
model clinic in 1999 to treat patients with chronic diseases
of rheumatological, gastrointestinal, pulmonological, and
cardiovascular origin, including those with chronic pain
syndromes. Referrals come from specialist and general
practitioners, with treatment costs being met by statutory
health insurance and many private health insurance com-
panies. The quality assurance program evaluates the Clinic’s
therapeutic results and cost-eﬀectiveness on behalf of the
North Rhine-Westphalia federal state government. Previous
partial publication of these results [16, 22] omitted the
first year of evaluation [22] and specific patient subgroups
[23]. Data on the Clinic’s cost-eﬀectiveness are not reported
here.
All patients admitted to the Clinic between January
2001 and January 2004 received detailed study information
and were invited to participate in this study. Patients who
were willing to participate signed informed consent forms.
Participants received questionnaires on their admission to
(ADM) and discharge from (DIS) a 2-week inpatient hospital
stay, with further questionnaires at 3-(FU3), 6-(FU6), and 12
month (FU12) intervals after discharge.
2.2. Intervention. Patients received two weeks of integrative
inpatient hospital treatment; following individual treatment
plans developed from extensive anamneses by physicians,
nurses, and mind/body therapists. Treatments included con-
ventional diagnostic and interventional medical approaches,
including physiotherapy, and the use of complementary tech-
niques. The latter included the use of traditional medicine
(Traditional ChineseMedicine, acupuncture, cupping, leech-
ing, etc.) and classical naturopathy (hydrotherapy, ther-
motherapy, manual therapy, massage, phytotherapy, exercise,
nutritional therapy, and fasting). Patients also received sev-
eral mind/body therapy sessions, focusing on exercise, stress-
reduction, diet, and self-help, to empower them to adopt
healthy lifestyles. These sessions were based on Harvard
Medical School’s Benson-Henry Institute for Mind/Body
Medicine Program [24] and the University of Massachusetts’
Mindfulness-Based Stress Reduction Program [25, 26]. Ele-
ments of cognitive restructuring were also added in this study
[27, 28].
2.3. Outcome Measures. The following were used to evaluate
patients’ postintervention change.
2.4. Primary Outcome Measure
2.4.1. Health Related Quality of Life (SF-36). Patients’ health-
related quality of life was assessed using the short form 36
of the health survey questionnaire (SF-36) [29]. This tool
measures individuals’ quality of life on eight dimensions
and two main component scales (physical, mental). It has
proven validity and reliability [29]. Each scale ranges from
0 to 100, with higher scores indicating higher quality of life.
In this study, only the main component summaries were
analysed; comparing the outcome with age- and gender-
matched values from the German general population [30,
31]. The diﬀerences found are presented as z-scores, with
0 representing the mean and 1 the standard deviation of
the population. The SF-36 assesses quality of life by means
of daily living activities, making its use inappropriate in a
hospital setting. The SF-36 was, therefore administered at
ADM, FU3, FU6, and FU12, but not at discharge, in this
study.
2.5. Secondary Outcome Measures
2.5.1. Anxiety and Depression (HADS). Changes in patients’
psychological symptoms were measured using the Hospital
Anxiety and Depression Scale (HADS). This tool has 14
items, scored on 4 point Likert scales [32]. Higher scores
indicate more severe symptoms. For both dimensions, cut-
oﬀ scores have been introduced to indicate possible sub-
syndromal (≥8) or clinically relevant (≥11) anxiety or
depression [33]. Study patients completed the HADS at
admission, discharge, and followup.
2.5.2. Health Locus of Control (GKU¨). Patients’ health locus
of control was measured using the GKU¨ (German abbre-
viation for Gesundheitsbezogene Kontrollu¨berzeugungen)
[34, 35] a short version in German of the Multidimensional
Health Locus of Control Questionnaire (MHLC) [36]. The
GKU¨ is a 9-item questionnaire which assesses three dimen-
sions of patients’ control beliefs: internal, external-social,
and external-fatalistic. The more internal control patients
perceive, the more they feel able to influence their health. By
contrast, the more control that patients attribute to others
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(external-social), or to luck or destiny (external-fatalistic),
the less they feel able to influence their health. The GKU¨ was
originally devised for use with patients with cancer, but has
since been adapted for use with other patients, such as those
with back pain [37]. A previous study reported problems
with one item on the GKU¨ [38]. A factor analysis undertaken
with the present study data showed that this item loaded on
two factors equally. It was therefore deleted from the analysis
[38]. Patients completed the GKU¨ at admission, discharge,
and followup.
2.5.3. Satisfaction with Health and Life in General (FLZ).
Patients’ satisfaction with their health and lives in general was
measured using two 5-point Likert items from the Life Satis-
faction Questionnaire (Fragebogen zur Lebenszufriedenheit,
FLZ) [39] at admission, discharge, and followup. The scale
used ranged from 1 = very dissatisfied to 5 = very satisfied,
with higher scores indicating patients’ greater satisfaction
with their health and lives in general.
2.5.4. Demand on Medical Services. The study questionnaire
also asked patients to record how many doctors’ visits they
had made during the previous month. Patients were also
asked, at admission and 12-month followup, how many days
they had been admitted for hospital inpatient treatment and
how many days they had missed work (where appropriate)
over the previous year.
2.5.5. Improvement in Disease-Related Symptoms. At dis-
charge and each followup, patients compared their main
disease-related symptoms with before they entered treat-
ment, using a 5-point Likert scale that ranged from “much
worse” to “much improved.”
2.5.6. Statistical Analysis. All analyses were based on full
data sets with no missing data. Baseline comparisons and
comparisons between responders and non-responders were
conducted using t-tests for independent groups, for para-
metric data, and x2-tests for nonparametric data. Responders
were defined as patients who returned their questionnaires
at given time points, with nonresponders being those who
failed to do so.
Repeated analyses of variance (ANOVA) were used to
analyse the study’s primary and secondary outcome meas-
ures as appropriate. Residuals were checked visually for
normal distribution. The homogeneity of variance was tested
using a Mauchly test for sphericity. Cases of nonsphericity
were corrected using a Greenhouse-Geisser correction. The
estimated diﬀerences between the time points, from the
ANOVA analyses, and their 95% Confidence Intervals, were
reported for each outcome. Eﬀect size Cohen’s d (the
estimated diﬀerences from the ANOVA analyses divided by
the standard deviation of patients’ admission scores) was also
given. Changes in patients’ disease-related symptoms were
explored solely descriptively.
Analyses were conducted in the following order to de-
termine the factors influencing the study’s primary outcome









returned at DIS (87.5%)
returned at FU3 (61.3%)
returned at FU6 (57.7%)
returned at FU12 (48.2%)
Figure 1: Flowchart of patient response rates.
possible links between patients’ sociodemographic char-
acteristics, their scores at admission and their outcome
at discharge and followup. (2) Factors with significant
correlations (r ≥ 0.1) were entered as possible predictors
into the regression analysis. Patients’ age and gender were
automatically included in each regression. (3) Linear forward
stepwise regression analysis with linear outcome and linear
or dichotomous regressors was then conducted.
All analyses were conducted using the Statistical Package
for the Social Sciences (SPSS) (Version 20.0, IBM, USA). The
significance level was set at α = 5%. An automatic Bonfer-
roni correction was applied for the posthoc comparison of
the main ANOVA eﬀects.
3. Results
3.1. Patients’ Characteristics. The study’s response rates are
shown in Figure 1. Of the 2804 patients treated between
January 2001 and January 2004, 2486 agreed to participate
in the study on admission. The initial response rate of 87.5%
on discharge, diminished to 61.3%, 57.7%, and 48.2% at 3, 6
and 12 months’ followup. The numbers of patients included
in the analyses are shown in each of the following tables.
Since only complete patients’ data sets were included in the
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analyses, a missing score at any time point led to exclusion of
this patient’s data.
Table 1 shows patients’ sociodemographic and clinical
characteristics on admission. The study sample consisted
mainly of women in their mid-50s; most of whom had
not been educated to A-level standard. Men more often
reported being in a relationship, with more education, more
frequent absenteeism from work over the past year and lower
expectations of improvement from their inpatient stay than
women.
More than two thirds of the patients experienced a
chronic pain condition, with back pain, headache, fibromyal-
gia and arthritis being the most frequently cited causes
for admission. More than half of the study patients were
diagnosed as severely aﬀected by their disease conditions,
with few being seen as only slightly aﬀected.
Most patients had high expectations of complementary
medicine’s eﬀectiveness, with more than 80% expecting
some improvement and few expecting none.
The following results compare responders’ and non-
responders’ sociodemographic and clinical characteristics
to indicate potential response bias, illustrate the primary
and secondary outcomes for patients with complete data
sets, and present the regression analysis, for patients with
complete data sets, to determine the factors associated
with improvements in their quality of life after inpatient
treatment.
3.2. Comparison of Responders and Nonresponders. An eighth
of patients (12.5%) were lost to followup between admission
and discharge. More than a third (38.7%) had withdrawn
within three months of discharge (FU3), the time of the
biggest withdrawal. Table 2 shows the significant diﬀerences
found between responders and nonresponders.
Table 2 shows that responders stayed longer in hospital,
experienced less psychological symptoms, and scored more
highly on the mental health component summary of the SF-
36 than non-responders. Responders’ levels of internal locus
of control were also higher at baseline, and their external-
fatalistic control beliefs lower, than nonresponders’. Three
months posttreatment, responders’ results also outstripped
non-responders’ with regard to their satisfaction with their
life in general and perceived improvements in their symp-
toms at discharge.
3.3. Primary Outcome Measure
3.3.1. Health-related Quality of Life (SF-36). The physical
(PCS) and mental component (MCS) summaries of patients’
SF-36 scores increased from admission to FU3; remaining
relatively stable thereafter, see Table 3. Repeated ANOVA
analyses showed a significant time eﬀect on both the PCS
(P < 0.0001) and the MCS (P < 0.0001). Patients’
physical (PCS) and mental component summaries (MCS)
were found to be significantly higher at FU3, FU6 and FU12,
when compared to admission. No statistical diﬀerences were
found between patients’ follow-up measurements. The eﬀect
sizes for patients’ PCS and MCS summaries were small
to moderate. Altogether 41.3% and 44.3% had increased
their PCS and MCS summaries respectively by more than
five points from discharge onwards; a clinically important
improvement in their quality of life [29].
Compared to age- and gender-matched data from a
normative German population, patients’ PCS was z = −1.49
and their MCS z = −0.97 at admission; below the average of
the corresponding norms. At FU3, study patients’ PCS was
z = −1.01 and their MCS = −0.47; an improvement of 0.5z.
3.4. Secondary Outcome Measures
3.4.1. Anxiety and Depression (HADS). ANOVA analyses
revealed significant time eﬀects on patients’ anxiety (P <
0.0001) and depression (P < 0.0001) scores. Post-hoc
analysis found patients’ scores to be significantly lower on
discharge and at followup than on admission. Although
HADS-A and HADS-D increased on followup, they were
still significantly lower than on admission. The eﬀect sizes
for anxiety and depression were moderate on discharge and
small at followup, see Table 3.
The proportion of patients with cut-oﬀ scores >8
(indicating subsyndromal anxiety or depression) and >11
(indicating a clinically relevant disorder) were relatively
high on admission (HADS A ≥ 8: 61.1%; HADS A ≥ 11:
35.5%; HADS D ≥ 8: 46.5%; HADS-D ≥ 11: 22.4%). These
scores were lower on both discharge (HADS A ≥ 8: 34.5%;
HADS A ≥ 11: 14.3%; HADS D ≥ 8: 22.0%; HADS D ≥ 11:
9.4%) and followup. At FU12, 33% less patients showed signs
of subsyndromal or clinically relevant anxiety or depression,
compared to admission (HADS A ≥ 8: 42.3%; HADS A ≥
11: 22.1%; HADS D ≥ 8: 31.9%; HADS D ≥ 11: 16.8%).
3.4.2. Health Locus of Control (GKU¨). Significant changes
were found for all three scales of the GKU¨ over time (all
P < 0.001). Discharge and follow-up scores were significantly
higher for internal and significantly lower external-social
control beliefs, compared to admission (see Table 3). Follow-
up scores were also higher for external-fatalistic beliefs.
The ratio of patients’ internal to external control beliefs,
suggesting a perceived shift in control beliefs, also increased
significantly over time (P < 0.001), with all follow-up scores
being significantly higher than on admission.
3.4.3. Satisfaction with Health and Life in General (FLZ).
Patients’ satisfaction scores are shown in Table 3. ANOVA
analysis showed significant time eﬀects (P < 0.001), with
increases in satisfaction with health found throughout the
follow-up period, compared to baseline. Patients’ satisfaction
with their lives in general was higher than their satisfaction
with their health, on average. The ANOVA results also
showed significant time eﬀects for patients’ satisfaction with
their lives in general (P < 0.001), with significant diﬀerences
found between baseline and all follow-up measurements.
The increase in the latter, however, was only marginally.
3.4.4. Demand onMedical Services. In the posttreatment year
(FU12), employed patients’ absenteeism from work fell by
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Table 1: Sociodemographic and clinical data of patients at admission.
All patients Female Male P
Complete sample size 2486 1994 492
Age (M ± SD; range) (N = 2486) 53.9 ± 14.3; 16–91 53.87 ± 14.3 54.8 ± 14.5 0.77
Family status (% in relationship/married) (N = 2438) 58.1 54.9 71.2 <0.001
Education (% with A-level and higher) (N = 2414) 26.3 24.0 35.8 <0.001
Number of doctors consultations within the past 4 weeks
(M ± SD; range) (N = 2241) 3.9 ± 3.4; 0–25 3.8 ± 3.2 4.2 ± 3.9 0.06
Days of sick leave in the past 12months (M ± SD; range) (N = 881) 25.9 ± 56.3; 0–365 23.6 ± 49.2 33.3 ± 74.7 0.03
Days admitted to hospitals within the past year (M ± SD; range) (N = 914) 21.4 ± 19.3; 2–70 21.2 ± 20.0 22.2 ± 19.1 0.53
Length of stay at the hospital in days (M ± SD; range) (N = 2486) 14.6 ± 3.6; 4–54 14.7 ± 3.6 14.1 ± 3.4 0.001
Expectancy of improvement (%) (N = 2398)
(i) Very much 44.8 48.2 31.7
<0.001
(ii) Somewhat 37.4 35.5 45.0
(iii) Unsure 16.6 15.3 21.7
(iv) Not so much 1.0 0.7 1.9
(v) Not at all 0.3 0.4 0.0
Major admission diagnosis (%) (N = 2486)
(i) Arthritis 6.7 7.2 4.7
(ii) Fibromyalgia 10.8 13.0 2.0
(iii) Headache 11.3 12.1 7.7
(iv) Hypertension 3.4 2.7 6.3
(v) IBD (Crohn, Colitis) 4.9 3.9 9.3
(vi) IBS 3.0 3.3 1.6
(vii) Ischemic cardiac disease 1.2 0.5 4.1
(viii) Lung diseases 5.5 5.7 4.5
(ix) Osteoarthritis 9.9 10.5 7.3
(x) Spinal Pain 18.8 18.2 21.5
(xi) Pain, others 10.9 10.5 12.4
(xii) Others 13.7 12.5 18.5
Physician rated severity of disease (%) (N = 2486)
Very severe 6.5 6.8 5.3
Severe 49.3 52.4 36.7
Moderate 39.1 37.2 46.8
Slight 4.2 3.1 8.7
Minor 0.9 0.5 2.5
M: mean; SD: standard deviation. For several variables, data were inconclusive. For work absenteeism, only scores from patients with full-time or part-time
employment were entered.
some 10 days (P < 0.0001). Patients’ visits to doctors in the
previous month were also significantly reduced (P < 0.0001).
No significant change occurred in the number of nights that
patients spent in hospital during this year.
3.4.5. Improvement of Disease-Related Symptoms. On dis-
charge, almost 80% of the study patients rated their health as
at least somewhat improved, with some 60% continuing to
do so 12 months later. In contrast, at FU12, a fifth of patients
(20%) saw their health as worse than before admission.
3.4.6. Predictors of Improvement in the Primary Outcome
Measure. All of patients’ socio-demographic and clinical
admission data with significant correlations of r ≥ 0.1
were entered into the predictor analysis, to determine the
factors influencing the changes found in their SF36 physical
(PCS) andmental (MCS) component summaries at 3-month
followup. The resulting analysis showed that change in
patients’ PCS score at FU3 was predicted by their PCS score
on admission (β = −0.33), their internal control beliefs on
admission (β = 0.13), age (β = −0.11), their MCS score on
admission (β = 0.13), a main diagnosis of a pain versus a
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Table 2: Significant diﬀerences at baseline characteristics and health change at discharge between responders and non-responders.
Characteristic Responders at DIS (M ± SD) Nonresponders at DIS (M ± SD) P
Length of stay at the hospital (in days) 14.8 ± 3.2 13.3 ± 5.5 <0.001
Internal control beliefs (GKU¨) 3.0 ± 0.9 2.9 ± 0.9 0.034
External-fatalistic control beliefs (GKU¨) 2.2 ± 0.9 2.4 ± 0.9 0.001
Depression (HADS) 7.4 ± 4.2 8.1 ± 4.2 0.01
Characteristic Responders at FU3 (M ± SD) Nonresponders at FU3 (M ± SD) P
Length of stay at the hospital (in days) 14.8 ± 3.0 14.3 ± 4.4 <0.001
External-fatalistic control beliefs (GKU¨) 2.2 ± 0.9 2.2 ± 0.9 0.01
External-social control beliefs (GKU¨) 2.8 ± 1.0 2.9 ± 1.1 0.035
Depression (HADS) 7.3 ± 4.1 7.9 ± 4.3 <0.001
Mental component summary (SF-36) 40.2 ± 12.9 38.7 ± 12.6 0.004
Satisfaction with life in general 3.4 ± 0.9 3.3 ± 0.9 0.01
Subjective health change at discharge (in %)
0.001
(i) Much improved 33.2 25.7
(ii) Somewhat improved 47.4 52.4
(iii) The same 15.8 16.5
(iv) Somewhat worse 2.7 3.9
(v) Much worse 0.9 1.5
DIS: discharge; FU3: 3-month followup; M: mean; SD: standard deviation.
nonpain condition (β = −0.09) and being employed (β =
0.09) (all P < 0.05). Patients’ MCS at FU3 was predicted
by their MCS score on admission (β = −0.55), a higher
educational level (β = 0.07), and their satisfaction both with
life in general (β = 0.15), and with health (β = 0.06) on
admission (all P < 0.05).
4. Discussion
4.1. Summary of the Results. This observational study inves-
tigated changes occurring in patients with chronic conditions
following a 2-week inpatient integrative program. The latter
combined conventional medicine, complementary medicine
and Mind/Body therapies aimed at empowering patients to
adopt a healthy lifestyle. The results revealed a small-to-
moderate, but sustained improvement in patients’ perceived
quality of life, with regard to both its physical and mental
health aspects. Patients also reported reduced anxiety and
depression, as measured on the Hospital Anxiety and
Depression Scale (HADS). At the same time, patients’ inter-
nal locus of control increased and their external-social con-
trol beliefs diminished. On the other hand, patients’ external-
fatalistic control beliefs rose significantly over time. Patients’
satisfaction with their health and lives in general increased.
Employed patients reported fewer days’ absenteeism and all
patients made fewer doctors’ visits during the posttreatment
year. Altogether, patients reported substantial benefit from
their two weeks of integrated inpatient treatment.
4.2. Comparisons with the Literature. The above results are
in line with those of other studies into the eﬀectiveness
of inpatient treatments that include naturopathy and Tra-
ditional Chinese Medicine [40–48]. Patients in these other
observational trials also showed improved symptoms and
health, as well as improved quality of life. The eﬀect sizes
were also comparable between these studies, for example,
Melchart et al. [47] found eﬀects around d = 0.5 for
changes to patients’ PCS and MCS after 6 months, changes
only marginally larger than those found in the present
study. More than two fifths of the patients in the present
study (42%) reported improvements of >5 points in the SF-
36, which is considered clinically relevant [49]. The eﬀect
sizes for the HADS anxiety and depression scales were
moderate on discharge and small on followup, although the
frequency with which patients scored above the cut-oﬀs for
subsyndromal and clinically relevant anxiety and depression
each fell by almost a third (33%).
Patients with chronic conditions often suﬀer from
comorbid psychological disorders. Falls in the levels of
anxiety and depression that patients reported in this study,
following their inpatient treatment may reflect improve-
ments in their overall health. Theymay also reflect the impact
of the psychosocial approaches used in the Mind/Body
therapy element of the treatment received.
The regression analysis conducted showed that the
change in the SF-36 physical component summary was
predicted by patients’ PCS score on admission. Patients with
lower PCS scores on admission benefited most, perhaps
because they began with very low scores and thus had more
room to improve. The eﬀect might also reflect a regression to
the mean.
For theMCS at baseline, the link was reversed. The higher
patients’ MCS scores were on admission, the more their
PCS scores improved at followup. Patients’ pain diagnoses,
age, and employment status also proved important in this
study. Patients who had nonpain diagnoses were younger
and were employed were more responsive, perhaps because




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8 Evidence-Based Complementary and Alternative Medicine
they had shorter disease histories and were potentially less
impaired than those unable to work. Comparable results
have been found for patients with low back pain [50, 51].
Together, these variables explained 12.4% of the variance
found, suggesting minor predictive power.
For improvements in patients’ MCS scores, lower MCS
scores at admission, higher levels of satisfaction with health
and life in general and a higher level of education proved
significant. Higher degrees of satisfaction might be linked to
greater levels of openness and appreciation which, together
with higher levels of education, might incline patients
towards psychosocial Mind/Body interventions. All of the
selected factors, taken together, explained 24.4% of the MCS
change variance found.
An internal locus of control proved the only signif-
icant factor predicting change in patients’ PCS scores,
but did not influence their MCS scores. Improvements
in patients’ physical health were perhaps linked to an
increased probability of adopting a healthy lifestyle in
patients with a more internal locus of control. Adequate
exercise, nutrition, and relaxation are certainly considered
important to overall health and mortality [52–54]. Further
research is needed to explore the link between patients’
locus of control and their actual behaviours, given that
neither external-social nor external-fatalistic control beliefs
predicted any study outcomes. Although patients’ external-
fatalistic control beliefs increased during inpatient treatment,
which was contrary to expectations, this change may reflect
the questionable discriminative power of the tool used. The
Mind/Body program oﬀered at the Department for Internal
and Integrative Medicine, based on similar programs used
elsewhere, draws on patients’ acceptance of their health
situations. Accepting patients might be mistakenly seen
to have high external-fatalistic control beliefs because the
questionnaire used cannot distinguish between these two
variables. The study data provide no conclusive evidence
about this matter. Further studies are therefore needed to
evaluate the relationship between patients’ locus of control
and their acceptance of their health situations. Data on
patients’ posttreatment demands on medical services was
also inconclusive, although there was some suggestion of
falls in absenteeism and the number of doctors’ visits
made.
4.3. Limitations of the Study. This study’s findings are
weakened by its observational design; the lack of a control
group renders the eﬀects indivisible from nonspecific eﬀects.
There may also have been some selection bias, as 11.3% of
all treated patients chose not to participate in the study.
Another problem resulted from the followup response rate
the loss of 50% of the patients at 12 months generating
much missing data. Whilst other quality assurance programs
have experienced similar response rates [41, 42], some have
lost only 25% of their participants [47]. The followup losses
experienced in the present study may mean that the reported
results reflect a bias in patients’ response behaviours. To
detect such a bias, responders’ and nonresponders’ socio-
demographic and baseline characteristics were compared.
Non-responders were found to have shorter clinic stays
(potentially reducing delivery of the study discharge ques-
tionnaire), more external-fatalistic control beliefs, higher
depression scores and less mental health than responders.
They also cited less symptomatic improvement on discharge
then responders. Taken together, these comparisons suggest
that patients with more disadvantageous control beliefs,
greater psychological symptoms and less benefit from treat-
ment were more often lost to followup. The reported eﬀects
might therefore be an overestimation and, in part, reflect
regression to the mean.
Since neither the patients nor the program has changed
for the most part, these data, retrieved about 10 years
ago, are still valid and the results generalizable to current
conditions. The Clinic still provides internal and external
quality assurance program, but with other quality indices.
4.4. Future Research. This study’s results suggest that patients
experience benefit from receiving two weeks of integrative
inpatient treatment, but more research is needed to confirm
and extend them. Future studies should use more rigorous
designs, such as randomised controlled trials, to explore links
between patients’ sociodemographic, clinical characteristics
and selected outcome measures, delving into the nature of
and mechanisms behind these links. They should also focus
on ways to enhance patient compliance.
5. Conclusion
The results of this study suggest that a 2-week inpatient
treatment might sustainably reduce patients’ somatic and
psychological symptoms and increase their quality of life;
however, conclusions are limited by the observational study
design and a high withdrawal rate. Increases in patients’
quality of life were predicted by several variables; the most
important being low quality of life at admission. More
research is needed for conclusive judgment of integrated
inpatient treatment programs’ eﬀectiveness and modes of
action.
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